Navigation Links
Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
Date:1/23/2015

NEW YORK, Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS), concerning whether the board has breached its fiduciary duties to shareholders.

On January 21, 2015, an article was published on an investing website reporting that Advaxis had misrepresented the clinical data for its ADXS-HPV drug in a recent corporate presentation by exaggerating its effectiveness.  Company stock fell over 25% on this news.

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Advaxis shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com 
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
3. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
4. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
5. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
6. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
7. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
8. Harwood Feffer LLP Announces Investigation of MAP Pharmaceuticals, Inc.
9. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
10. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
11. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... ... in vitro toxicology testing solutions, announced the addition of the Human MDR-1 ... existing in vitro toxicology offerings and allows researchers to perform critical toxicology testing ...
(Date:6/18/2019)... , ... June 18, 2019 , ... ... new facilities at 11500 W Olympic Blvd Suite 350 Los Angeles, CA, 90064, ... through research-backed methodologies. , MY Education Guru has created individual programs to ...
(Date:6/18/2019)... Tenn. (PRWEB) , ... June 18, 2019 , ... ... leader in emergency medicine and hospital medicine management services, are pleased to announce ... company based in Longview, Texas. , LEMA’s 34 physicians and 9 advanced ...
Breaking Medicine Technology:
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor Employees’ ... one of the world’s largest job and recruiting sites, released its annual report recognizing ... North America and parts of Europe. , Smile Brands, a leading dental support organization ...
(Date:6/19/2019)... ... June 19, 2019 , ... LifeLearn Animal Health launches ... pet insurance is, what it isn’t, and the questions they need to ask prior ... from different pet insurance companies and find the coverage that meets their budget and ...
(Date:6/18/2019)... ... June 18, 2019 , ... NeoTract, a wholly owned subsidiary ... urology, today announced that Aaron Berger, MD, Associated Urological Specialists, LLC in Chicago ... that Dr. Aaron Berger has achieved a high level of training and experience ...
(Date:6/16/2019)... ... June 16, 2019 , ... Ted Danson on CNBC ... research for the advancement of medical marijuana-based pharmaceuticals in an upcoming episode, scheduled ... more information. , With two investigational new drug applications already accepted by the ...
(Date:6/13/2019)... ... June 13, 2019 , ... MMJ BioPharma Cultivation, ... signed a memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis ... , MMJ BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana ...
Breaking Medicine News(10 mins):